MUSTANG BIO, INC. Restricted Cash
MUSTANG BIO, INC. (MBIO) had Restricted Cash of $750.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-05-12
- 2023-03-31: Restricted Cash $750.00K.
- 2022-12-31: Restricted Cash $1.00M.
- 2022-09-30: Restricted Cash $1.00M.
- 2022-06-30: Restricted Cash $1.00M.
| Period end | Restricted Cash |
|---|---|
| 2023-03-31 | $750.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.00M 10-Q · filed 2023-05-12 |
| 2022-09-30 | $1.00M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-12 |
| 2021-09-30 | $1.00M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $1.00M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $1.00M 10-Q · filed 2022-05-12 |
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |